Subscribe to Updates

    Get the latest creative news from CRYPTO NOUNCE.

    What's Hot

    Australia would not allow AT1 debt security holder wipe-out -minister By Reuters

    March 27, 2023

    Daily Crunch: Twitter tells GitHub to remove proprietary source code and help them ID who posted it

    March 27, 2023

    Max Q: A lifeline | TechCrunch

    March 27, 2023
    Facebook Twitter Instagram
    Facebook Twitter Instagram Vimeo
    Cryptonounce.com
    Contact
    • Business
      • Deals
      • investors
      • IPO
      • Startups
      • Wall Street
    • Markets
      • Bonds
      • Commodities & Futures
      • Currencies
      • Funds & ETFs
      • Stocks
    • Crypto
      • Alticoins News
      • Binance News
      • Bitcoins News
      • Blockchain News
      • Ethereum News
      • Token Sales News
      • XRP News
    • Technology
      • Artificial Intelligence
      • Big Data
      • Cloud Computing
      • Cybersecurity
      • Gaming
      • Internet of Things
      • Mobile
      • Social Media
      • Transportation
      • VR & AR
    • FinTech
    • Personal finance
    • Grides
      • Crypto
      • FinTech
      • Investing
      • Personal Finance Guides
      • Techonology
    • Tools
      • Coins
      • ICO List
      • Organigations
      • Events
    Cryptonounce.com
    Home » Casi Pharmaceuticals to run clinical trial for multiple myeloma drug in China
    Markets

    Casi Pharmaceuticals to run clinical trial for multiple myeloma drug in China

    AdmincryptBy AdmincryptJanuary 6, 2023No Comments1 Min Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Shares of Casi Pharmaceuticals Inc.
    CASI,
    +0.50%

    were up 10% in premarket trading on Friday after the company said China will allow a Phase 1 clinical trial evaluating a multiple myeloma drug developed by the privately held Cleave Therapeutics. The study is expected to start this year. Casi has a subsidiary in Beijing that supports its focus on acquiring and commercializing therapies for the Chinese market. The company’s stock is down 73.9% over the past 12 months, while the broader S&P 500
    SPX,
    +2.28%

    has declined 19.0%.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleCathie Wood’s ARK enters 2023 with $5.7M Coinbase stock purchase
    Next Article Singapore’s lobbyists oppose proposed blanket ban on lending crypto tokens
    Admincrypt
    • Website

    Related Posts

    Australia would not allow AT1 debt security holder wipe-out -minister By Reuters

    March 27, 2023

    Lyft taps former Amazon exec Risher as new CEO after founders step down By Reuters

    March 27, 2023

    Pinterest sheds S.F. office space

    March 27, 2023

    Toronto market gains, led by energy and financial shares By Reuters

    March 27, 2023

    Leave A Reply Cancel Reply

    Our Picks
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss
    Stocks

    Australia would not allow AT1 debt security holder wipe-out -minister By Reuters

    By AdmincryptMarch 27, 20230

    © Reuters. SYDNEY (Reuters) – Australian law would not allow regulators to wipe out AT1…

    Daily Crunch: Twitter tells GitHub to remove proprietary source code and help them ID who posted it

    March 27, 2023

    Max Q: A lifeline | TechCrunch

    March 27, 2023

    5 Ways to Make the Most Out of an Industry Conference

    March 27, 2023

    Subscribe to Updates

    Get the latest creative news from CRYPTO NOUNCE.

    NEWS
    • Business
    • Crypto
    • Blockchain
    • Markets
    • Technology
    FEATURED SECTIONS
    • Coins
    • ICO List
    • Organigations
    • Events
    • Grides
    FEATURED LINKS
    • Story of the day
    • Videos
    • Infographics
    CONNECT WITH US
    • Facebook
    • Twitter
    • Telegram
    • LinkedIn
    • Pinterest
    ABOUT US
    • Contact
    • Advertise
    • Sitemap
    Copyright © 2023 Cryptonounce All rights reserved. Cryptonounce.
    • Home
    • Buy Now

    Type above and press Enter to search. Press Esc to cancel.

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?